03.07.2015 Views

July - Summer Edition - CI Investments

July - Summer Edition - CI Investments

July - Summer Edition - CI Investments

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Commentary<br />

eBay and Wienerberger. Cash at the end of the quarter was<br />

about 4% of the fund, compared to just over 2% at the end of<br />

March and 5% at the beginning of the year.<br />

Castlerock International Equity Fund<br />

We have been selectively adding to our more cyclical holdings<br />

as we had cut them back one year ago. We are finding new<br />

investments in emerging markets and in technology. Our<br />

holdings in companies like Adidas, Glanbia and Galp<br />

Energia have done very well and our Japanese investments<br />

snapped back in value once investors determined that the<br />

tsunami would have little effect on their performance.<br />

What is truly ironic is that the best-performing areas of the<br />

world have been U.S. and European equities this year, proving<br />

that investors overlook and overreact regularly to bad news.<br />

One such area is Chinese equities. We have been looking<br />

at Chinese companies for a very long time (since 1994), yet<br />

we have just started to make commitments now. We seek out<br />

market share-leading companies with sustainable competitive<br />

advantages at reasonable prices that have established<br />

management teams who work for the shareholders. To get<br />

all of these characteristics in a Chinese company is tough.<br />

We have long been very skeptical of the internal allocation of<br />

capital within Chinese companies and also the accounting<br />

for their activities. With recent high-profile compliance<br />

problems, it is our judgment that the cleanup will be<br />

effective. We never doubt the internal drive of the Chinese<br />

business community to be world class in everything they do.<br />

It is their driving force. So we have invested in a Chinese<br />

clinical research company run by former executives from<br />

GSK-Wuxi Pharmatech.<br />

Castlerock Global Balanced Fund<br />

Castlerock Global Balanced Fund performed in line with the<br />

benchmark index for the six-month period. We experienced<br />

a notable loss in one holding – Irish Life – in the quarter as<br />

a desperate new government sought to distance itself from<br />

the previous government and rewrite the regulatory rules<br />

for banks and insurance holding companies. Although legal<br />

actions are underway, the losses have been taken.<br />

It is easy to feel despondent, but then we look at what is<br />

happening with the businesses we own in our focused<br />

international portfolio. Most are doing well, some exceedingly<br />

so. At a valuation level below the long-term global average,<br />

this should yield reasonably good equity results. But when,<br />

we just do not know. The reverse seems to be true in the<br />

fixed-income world. Investors seem to view risk in a binary<br />

fashion. That is, they love the government debt of a country<br />

and then they dump it in a lemming-like behaviour when<br />

they no longer agree that country is credit worthy. To this<br />

point, we have systematically lowered our fixed-income<br />

exposure to government securities as they have risen in price<br />

to the point where we see little long-term value. While it is<br />

costly in total rates of return, we have shortened our exposure<br />

to short-term government securities in wait for opportunities<br />

to buy quality corporate exposures at higher yields.<br />

It seems certain now that the pace of earnings growth will<br />

slow down from recovery levels to normal 4% to 6% levels.<br />

This slowdown has caught some investors off guard, most<br />

notably in the cyclical investment areas like emerging<br />

markets, commodities and cyclical stocks. We have felt<br />

a limited pullback in our portfolio, notably in our smaller<br />

Brazilian holdings and in our construction-oriented<br />

companies and semiconductor holdings.<br />

We have been selectively adding to our more cyclical holdings<br />

as we had cut them back one year ago. We are finding new<br />

investments in emerging markets and in technology. Our<br />

holdings in companies like Adidas, GlaxoSmithKline,<br />

Northrup Grumman, Glanbia, Affymetrix and Galp Energia<br />

have done very well. Our Japanese investments have also<br />

snapped back in value once investors determined that the<br />

tsunami had little effect on these companies.<br />

Director of Equities: Matias Galarce, Evelyn Huang<br />

SUMMER 2011 PERSPECTIVE AS AT JUNE 30, 2011 31

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!